News

Bayer’s management board approves €700million investment

03/03/2006

The Bayer AG Board of Management has approved an investment package totalling €700 million, which Bayer MaterialScience AG will use to expand its capacities for key products. In addition to two major projects at the Caojing site in Shanghai, the investment package also includes expansion of production in the United States and refurbishment of the future Group headquarters of Bayer MaterialScience in Leverkusen.

To continue reading this story, please sign in or register.